Neuralink's 2023 announcement of its PRIME study, after the FDA allowed a clinical investigation in May 2023. The implant records brain signals and sends them wirelessly to an app.
The initial goal of the PRIME Study is to demonstrate that the N1 Implant is safe and useful in restoring autonomy to those living with paralysis.
Neuralink's 2023 announcement of its PRIME study, after the FDA allowed a clinical investigation in May 2023. The implant records brain signals and sends them wirelessly to an app.